Your cart is currently empty.
Studied in human clinical trials: B. longum BB536, L. rhamnosus R0011 and L. helveticus R0052 are well characterized and have been shown to interact via multiple mechanisms of action with the intestinal tract and the microbial ecosystem within it.* These strains have been clinically shown to support the properties of the intestinal microflora, promote intestinal health and support immune response.*
QUESTIONS & ANSWERS
Have a Question?
Be the first to ask a question about this.